04:44 PM EDT, 03/28/2025 (MT Newswires) -- Nektar Therapeutics ( NKTR ) has filed a mixed shelf registration statement to raise up to $300 million, according to a Friday filing.

The filing covers the sale of its common shares, preferred shares, debt securities, warrants, and units in one or more issuances.

The sale will be held from "time to time" and proceeds will be used for general corporate purposes, the company said.